Non-surgical therapy for the patients with advanced non-small cell lung cancer

Respirology

Volumn 3, Issue 3, 1998, Pages 159-166

  Lee, Choon Taek ^a  

^a Seoul National University   (South Korea)

Author keywords

Advanced NSCLC; Chemotherapy; Combined treatment; Concurrent chemoradiotherapy; Gene therapy; Radiation therapy; Sequential chemoradiotherapy

Indexed keywords

CISPLATIN; MITOMYCIN C; VINBLASTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; ESOPHAGITIS; GENE THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SURVIVAL TIME;

EID: 0031794839     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.1998.tb00115.x     Document Type: Review

References (17)

1. Lee SI, Park HG, Ahn DH et al. Analysis reports on cancer registry in Korea. Korea Ministry of Health and Welfare 1996; 18: 18.
2. SEER Statistics review 1973-1992. NIH publication No 96-2789. National Cancer Institute, 1995.
3. Masironi R, Rothwell K. Trends in cigarette smoking in the world. World Health Stat. Q. 1988; 41: 228.
4. Ginsberg RJ, Vokes EE, Raben A. Non-small cell lung cancer. In: DeVita VT (ed.) Cancer. Principle and Practice of Oncology. Lippincott-Raven, Philadelphia, 1997: 858-911.
5. Wagner H Jr. Radiation therapy in the management of patients with unresectable stage IIIA and IIIB non-small cell lung cancer. Semin. Oncol. 1997; 24: 423-8.
6. Hilton G. Present position relating to cancer of the lung: Results with radiotherapy alone. Thorax 1960; 15: 17.
7. Park JG, Won JH, Cha SI et al. The prognosis following radiation therapy or surgical resection for stage I non-small cell lung cancer. Tuberc. Respir. Dis. 1995; 42: 731-6 (in Korean).
8. Payne DG. Non-small cell lung cancer: Should unresectable stage III patients routinely receive high-dose radiation therapy? J. Clin. Oncol. 1988; 6: 552.
9. Kim MS, Yoo SY, Cho CK et al. The results of radiation therapy in locally advanced non-small cell lung cancer. J. Korean Soc. Ther. Radiol Oncol. 1997; 15: 233-41 (in Korean).
10. Kay CS, Jang HS, Gil HJ, Yoon SC, Shinn KS. The results of radiation therapy in non-small cell lung cancer. J. Korean Soc. Ther. Radiol. 1994; 12: 175-84 (in Korean).
11. Withers MR, Thomas MD, Peters LJ. Differences in the fractination responses of acutely and late responding tissues. In: Kaercher KM, Kogelnik D, Reinartz G (eds) Progress in Radio-Oncology. Raven, New York, 1982: 287.
12. Cox JD, Azarnia N, Byhardt RW et al. A randomized phase I/II trial of hyperfractinated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with >69.6 Gy in favorable patients with stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 1990; 8: 1543-55.
13. Choi EK, Kim JH, Chang H et al. Hyperfractinated radiotherapy and concurrent chemotherapy for stage III unresectable non-small cell lung cancer: Preliminary report for response and toxicity. J. Korean Soc. Ther. Radiol. 1995; 13: 157-61 (in Korean).
14. Armstrong JG, Burman C, Leibel S et al. Three dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int. J. Radiot. Oncol. Biol. Phys. 1993; 26: 685-9.
15. Choi EK, Lee BY, Chang HS et al. New 3 dimensional conformal radiation therapy in non-small cell lung cancer. Tuberc. Respir. Dis. 1997; 44: S99 (in Korean).
16. Ahn YC, Lim DH, Choi DR et al. Short-term results of endobronchial brachytherapy for malignant airway obstructions. J. Korean Soc. Ther. Radiol. Oncol. 1996; 14: 299-305 (in Korean).
17. Ramanathan RK, Belani CP. Chemotherapy for advanced non-small cell lung cancer: Past, present, and future. Semin. Oncol. 1997; 24: 440-54.